Hyperamylasemia in kidney transplant recipients.
Yokoyama
I
I
Department of Surgery II, Nagoya University, School of Medicine, Japan.
Hayashi
S
S
Kobayashi
T
T
Negita
M
M
Katayama
A
A
Nagasaka
R
R
Namii
Y
Y
Kojima
T
T
Koike
C
C
Uchida
K
K
Takagi
H
H
D000410:Alanine Transaminase / Q000097:blood; D000681:Amylases / Q000097:blood* / Q000378:metabolism; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005190:Family; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D014019:Tissue Donors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000681:Amylases; D001379:Azathioprine; D011241:Prednisone